Evidence supporting the use of: Eicosapentaenoic Acid
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Eicosapentaenoic Acid (EPA) is an omega-3 polyunsaturated fatty acid found primarily in fish oil, and its use in Parkinson’s Disease (PD) is supported by limited scientific evidence. The rationale for EPA supplementation in PD is based on its potential neuroprotective, anti-inflammatory, and membrane-stabilizing effects. Some small-scale clinical studies and preclinical research suggest that omega-3 fatty acids, including EPA, can reduce neuroinflammation and oxidative stress, both implicated in PD pathogenesis. For example, a randomized controlled trial (da Silva et al., 2008) found that omega-3 supplementation, combined with antioxidant vitamins, led to improvements in depression symptoms in PD patients. However, its direct effect on the motor symptoms or progression of PD remains unclear, and larger, high-quality trials are lacking.

EPA is not a standard or primary therapy for PD, and medical guidelines do not currently recommend its use for disease modification or symptomatic management. The evidence base is limited to small studies with mixed outcomes, and most research has focused on the general neuroprotective effects of omega-3s rather than EPA specifically. As such, while there is scientific interest and some preliminary data, the strength of evidence is weak and does not support routine use of EPA as a treatment for Parkinson’s Disease at this time.

More about Eicosapentaenoic Acid
More about Parkinson's Disease

Products containing Eicosapentaenoic Acid

We currently have no products on Caring Sunshine that contain this ingredient.